Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway

Genes and Development

Volumn 20, Issue 24, 2006, Pages 3440-3452

  Schwarzkopf, Martina ^a   Coletti, Dario ^b   Sassoon, David ^a,c,d   Marazzi, Giovanna ^a,c,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Cancer cachexia; Muscle differentiation; p53; Pax7; PW1 Peg3; Skeletal muscle

Indexed keywords

PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CACHEXIA; CELL DIFFERENTIATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; STEM CELL;

ANIMALS; CACHEXIA; CELL SEPARATION; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASMS, EXPERIMENTAL; PROTEIN KINASES; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845697226     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.412606     Document Type: Article

References (81)

1. Acharyya, S., Butchbach, M.E., Sahenk, Z., Wang, H., Saji, M., Carathers, M., Ringel, M.D., Skipworth, R.J., Fearon, K.C., Hollingsworth, M.A., et al. 2005. Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8: 421-432.
2. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J., et al. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3: 1014-1019.
3. Cai, D., Frantz, J.D., Tawa Jr., N.E., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J., et al. 2004. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119: 285-298.
4. Charge, S.B. and Rudnicki, M.A. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84: 209-238.
5. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.L., Gottlieb, G.J., Greider, C.W., and DePinho, R.A. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538.
6. Chung, L. and Ng, Y.C. 2006. Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscle. Biochim. Biophys. Acta 1762: 103-109.
7. Coletti, D., Yang, E., Marazzi, G., and Sassoon, D. 2002. TNFα inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21: 631-642.
8. Coletti, D., Moresi, V., Adamo, S., Molinaro, M., and Sassoon, D. 2005. Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43: 119-127.
9. Dasarathy, S., Dodig, M., Muc, S.M., Kalhan, S.C., and McCullough, A.J. 2004. Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1124-G1130.
10. De Angelis, L., Berghella, L., Coletta, M., Lattanzi, L., Zanchi, M., Cusella-De Angelis, M.G., Ponzetto, C., and Cossu, G. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J. Cell Biol. 147: 869-878.
11. Degenhardt, K. and Sassoon, D.A. 2001. A role for Engrailed-2 in determination of skeletal muscle physiologic properties. Dev. Biol. 231: 175-189.
12. Deng, Y. and Wu, X. 2000. Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc. Natl. Acad. Sci. 97: 12050-12055.
13. Desplanches, D., Mayet, M.H., Sempore, B., and Flandrois, R. 1987. Structural and functional responses to prolonged hindlimb suspension in rat muscle. J. Appl. Physiol. 63: 558-563.
14. Dona, M., Sandri, M., Rossini, K., Dell'Aica, I., Podhorska-Okolow, M., and Carraro, U. 2003. Functional in vivo gene transfer into the myofibers of adult skeletal muscle. Biochem. Biophys. Res. Commun. 312: 1132-1138.
15. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery Jr., C.A., Butel, J.S., and Bradley, A. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
16. Garry, D.J., Meeson, A., Elterman, J., Zhao, Y., Yang, P., Bassel-Duby, R., and Williams, R.S. 2000. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc. Natl. Acad. Sci. 97: 5416-5421.
17. Glass, D.J. 2003a. Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9: 344-350.
18. Glass, D.J. 2003b. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5: 87-90.
19. Gomes, M.D., Lecker, S.H., Jagoe, R.T., Navon, A., and Goldberg, A.L. 2001. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. 98: 14440-14445.
20. Grounds, M.D. and Torrisi, J. 2004. Anti-TNFα (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 18: 676-682.
21. Guttridge, D.C., Albanese, C., Reuther, J.Y., Pestell, R.G., and Baldwin Jr., A.S. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19: 5785-5799.
22. Guttridge, D.C., Mayo, M.W., Madrid, L.V., Wang, C.Y., and Baldwin Jr., A.S. 2000. NF-κB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 289: 2363-2366.
23. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A.B. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
24. Inui, A. 2002. Cancer anorexia-cachexia syndrome: Current issues in research and management. CA Cancer J. Clin. 52: 72-91.
25. Israel, A. 2000. The IKK complex: An integrator of all signals that activate NF-κB? Trends Cell Biol. 10: 129-133.
26. Itahana, K., Dimri, G., and Campisi, J. 2001. Regulation of cellular senescence by p53. Eur. J. Biochem. 268: 2784-2791.
27. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., and Weinberg, R.A. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
28. Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., and Cabello, G. 2003. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp. Cell Res. 286: 263-275.
29. Komarov, P.G., Komarova, E.A., Kondratov, R.V., Christov-Tselkov, K., Coon, J.S., Chernov, M.V., and Gudkov, A.V. 1999. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737.
30. Kurabayashi, M., Jeyaseelan, R., and Kedes, L. 1993. Antineoplastic agent doxorubicin inhibits myogenic differentiation of C2 myoblasts. J. Biol. Chem. 268: 5524-5529.
31. Kurabayashi, M., Jeyaseelan, R., and Kedes, L. 1994. Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction. J. Biol. Chem. 269: 6031-6039.
32. Langen, R.C., Van Der Velden, J.L., Schols, A.M., Kelders, M.C., Wouters, E.F., and Janssen-Heininger, Y.M. 2004. Tumor necrosis factor-α inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 18: 227-237.
33. Latella, L., Lukas, J., Simone, C., Puri, P.L., and Bartek, J. 2004. Differentiation-induced radioresistance in muscle cells. Mol. Cell. Biol. 24: 6350-6361.
34. Li, Y.P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D.L., and Reid, M.B. 2005. TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 19: 362-370.
35. Lim, D.S., Vogel, H., Willerford, D.M., Sands, A.T., Platt, K.A., and Hasty, P. 2000. Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell. Biol. 20: 3772-3780.
36. Machida, S. and Booth, F.W. 2004. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp. Gerontol. 39: 1521-1525.
37. Machida, S. and Booth, F.W. 2005. Changes in signalling molecule levels in 10-day hindlimb immobilized rat muscles. Acta Physiol. Scand. 183: 171-179.
38. Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., and Scrable, H. 2004. Modulation of mammalian life span by the short isoform of p53. Genes & Dev. 18: 306-319.
39. Mauro, A. 1961. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9: 493-495.
40. McGeachie, J.K. and Grounds, M.D. 1987. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study. Cell Tissue Res. 248: 125-130.
41. Megeney, L.A., Kablar, B., Garrett, K., Anderson, J.E., and Rudnicki, M.A. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes & Dev. 10: 1173-1183.
42. Miller, S.C., Ito, H., Blau, H.M., and Torti, F.M. 1988. Tumor necrosis factor inhibits human myogenesis in vitro. Mol. Cell. Biol. 8: 2295-2301.
43. Mitchell, P.O. and Pavlath, G.K. 2004. Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells. Am. J. Physiol. Cell Physiol. 287: C1753-C1762.
44. Muscaritoli, M., Bossola, M., Bellantone, R., and Rossi Fanelli, F. 2004. Therapy of muscle wasting in cancer: What is the future? Curr. Opin. Clin. Nutr. Metab. Care 7: 459-466.
45. Nicolas, N., Marazzi, G., Kelley, K., and Sassoon, D. 2005. Embryonic deregulation of muscle stress signaling pathways leads to altered postnatal stem cell behavior and a failure in postnatal muscle growth. Dev. Biol. 281: 171-183.
46. Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M.C., and Li, G.C. 1996. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382: 551-555.
47. Olguin, H.C. and Olwin, B.B. 2004. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: A potential mechanism for self-renewal. Dev. Biol. 275: 375-388.
48. Oustanina, S., Hause, G., and Braun, T. 2004. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J. 23: 3430-3439.
49. Persons, C.C., Hermens, A.F., Franken, N.A., and Wondergem, J. 2001. Muscle wasting after radiotherapy in young and adult rats. Oncol. Rep. 8: 1117-1122.
50. Porrello, A., Cerone, M.A., Coen, S., Gurtner, A., Fontemaggi, G., Cimino, L., Piaggio, G., Sacchi, A., and Soddu, S. 2000. p53 regulates myogenesis by triggering the differentiation activity of pRb. J. Cell Biol. 151: 1295-1304.
51. Puri, P.L., Bhakta, K., Wood, L.D., Costanzo, A., Zhu, J., and Wang, J.Y. 2002. A myogenic differentiation checkpoint activated by genotoxic stress. Nat. Genet. 32: 585-593.
52. Reid, M.B. and Li, Y.P. 2001. Tumor necrosis factor-α and muscle wasting: A cellular perspective. Respir. Res. 2: 269-272.
53. Relaix, F., Weng, X., Marazzi, G., Yang, E., Copeland, N., Jenkins, N., Spence, S.E., and Sassoon, D. 1996. Pw1, a novel zinc finger gene implicated in the myogenic and neuronal lineages. Dev. Biol. 177: 383-396.
54. Relaix, F., Wei, X.J., Wu, X., and Sassoon, D.A. 1998. Peg3/Pw1 is an imprinted gene involved in the TNF-NFκB signal transduction pathway. Nat. Genet. 18: 287-291.
55. Relaix, F., Wei, X., Li, W., Pan, J., Lin, Y., Bowtell, D.D., Sassoon, D.A., and Wu, X. 2000. Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. Proc. Natl. Acad. Sci. 97: 2105-2110.
56. Rudolph, K.L., Chang, S., Lee, H.W., Blasco, M., Gottlieb, G.J., Greider, C., and DePinho, R.A. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701-712.
57. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H., and Goldberg, A.L. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
58. Schuler, M. and Green, D.R. 2001. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29: 684-688.
59. Seale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and Rudnicki, M.A. 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102: 777-786.
60. Seale, P., Ishibashi, J., Holterman, C., and Rudnicki, M.A. 2004. Muscle satellite cell-specific genes identified by genetic profiling of MyoD-deficient myogenic cell. Dev. Biol. 275: 287-300.
61. Siu, P.M. and Alway, S.E. 2005. Id2 and p53 participate in apoptosis during unloading-induced muscle atrophy. Am. J. Physiol. Cell Physiol. 288: C1058-C1073.
62. Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M.G., Bossi, G., Cimino, L., Crescenzi, M., and Sacchi, A. 1996. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134: 193-204.
63. Sturlan, S., Beinhauer, B.G., Oberhuber, G., Huang, L., Aasen, A.O., and Rogy, M.A. 2002. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice. Anticancer Res. 22: 2547-2554.
64. Szalay, K., Razga, Z., and Duda, E. 1997. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur. J. Cell Biol. 74: 391-398.
65. Tamir, Y. and Bengal, E. 1998. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene 17: 347-356.
66. Tanaka, Y., Eda, H., Tanaka, T., Udagawa, T., Ishikawa, T., Horii, I., Ishitsuka, H., Kataoka, T., and Taguchi, T. 1990. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 50: 2290-2295.
67. Tisdale, M.J. 2001. Loss of skeletal muscle in cancer: Biochemical mechanisms. Front. Biosci. 6: D164-D174.
68. Tisdale, M.J. 2002. Cachexia in cancer patients. Nat. Rev. Cancer 2: 862-871.
69. Todorov, P.T., Field, W.N., and Tisdale, M.J. 1999. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361). Br. J. Cancer 80: 1734-1737.
70. Tyner, S.D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53.
71. Varela, I., Cadinanos, J., Pendas, A.M., Gutierrez-Fernandez, A., Folgueras, A.R., Sanchez, L.M., Zhou, Z., Rodriguez, F.J., Stewart, C.L., Vega, J.A., et al. 2005. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437: 564-568.
72. Vogel, H., Lim, D.S., Karsenty, G., Finegold, M., and Hasty, P. 1999. Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl. Acad. Sci. 96: 10770-10775.
73. Vousden, K.H. 2000. p53: Death star. Cell 103: 691-694.
74. Vousden, K.H. and Woude, G.F. 2000. The ins and outs of p53. Nat. Cell Biol. 2: E178-E180.
75. Walsh, K. and Perlman, H. 1997. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7: 597-602.
76. Weintraub, H., Hauschka, S., and Tapscott, S.J. 1991. The MCK enhancer contains a p53 responsive element. Proc. Natl. Acad. Sci. 88: 4570-4571.
77. Welle, S., Brooks, A.I., Delehanty, J.M., Needler, N., Bhatt, K., Shah, B., and Thornton, C.A. 2004. Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women. Exp. Gerontol. 39: 369-377.
78. White, J.D., Rachel, C., Vermeulen, R., Davies, M., and Grounds, M.D. 2002. The role of p53 in vivo during skeletal muscle post-natal development and regeneration: Studies in p53 knockout mice. Int. J. Dev. Biol. 46: 577-582.
79. Yarasheski, K.E., Bhasin, S., Sinha-Hikim, I., Pak-Loduca, J., and Gonzalez-Cadavid, N.F. 2002. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J. Nutr. Health Aging 6: 343-348.
80. Zammit, P.S., Golding, J.P., Nagata, Y., Hudon, V., Partridge, T.A., and Beauchamp, J.R. 2004. Muscle satellite cells adopt divergent fates: A mechanism for self-renewal? J. Cell Biol. 166: 347-357.
81. Zimmers, T.A., Davies, M.V., Koniaris, L.G., Haynes, P., Esquela, A.F., Tomkinson, K.N., McPherron, A.C., Wolfman, N.M., and Lee, S.J. 2002. Induction of cachexia in mice by systemically administered myostatin. Science 296: 1486-1488.